insights_auto
Outlook: 39.1% bullish·8.7% bearish
Go to analysischevron_right
UNH:NYSE
UnitedHealth Group Inc
$369.83
arrow_upward
+1.27%(+4.64) 1D
Oct 2, 2:49:58 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UNH...
Open
$365.14
High
$370.24
Low
$364.47
Mkt. cap
332.02B
Avg. vol.
4.77M
Volume
1.64M
Dividend
2.51%
Quarterly dividend
$2.32
Ex-dividend date
Sep 14, 2026
P/E ratio
23.79
52-wk high
$461.62
52-wk low
$255.96
EPS
$15.55
Beta
0.60
Shares outstanding
897.60M
No. of employees
390K
Open
$365.14
High
$370.24
Low
$364.47
Mkt. cap
332.02B
Avg. vol.
4.77M
Volume
1.64M
Dividend
2.51%
Quarterly dividend
$2.32
Ex-dividend date
Sep 14, 2026
P/E ratio
23.79
52-wk high
$461.62
52-wk low
$255.96
EPS
$15.55
Beta
0.60
Shares outstanding
897.60M
No. of employees
390K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
UnitedHealth and Humana cutting Medicare Advantage plans in 2027
Investing.com India
·
1 day ago
Form 4 Unitedhealth Group For: 1 October
About UnitedHealth Group Inc
CEOStephen J. Hemsley
Employees390K
FoundedJan 1977
Headquarters-
SectorHealth care provider
Websiteunitedhealthgroup.com
Analyst ratings
Based on 22 analysts giving stock ratings to UNH in the past 3 months
Strong buy
Buy
17
Hold
5
Sell
0
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for UNH in the last 3 months.
Highest
Current $369.83
$529.00 (+43.04%)
Average
$481.58 (+30.22%)
Lowest
$380.00 (+2.75%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Stephen Baxter Wells Fargo | Buy | Maintained | $526.00 | +42.2% | 09/15/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $480.00 | +29.8% | 09/14/2026 |
A.J. Rice UBS | Buy | Maintained | $490.00 | +32.5% | 09/14/2026 |
Andrew Mok CFA Barclays | Buy | Maintained | $441.00 | +19.2% | 09/10/2026 |
Lance Wilkes Bernstein | Buy | Maintained | $512.00 | +38.4% | 09/09/2026 |
Hans Engel Erste Group | Hold | Downgraded | - | - | 08/27/2026 |
George Hill Deutsche Bank | Hold | Maintained | - | - | 08/03/2026 |
Lisa Gill J.P. Morgan | Buy | Maintained | $516.00 | +39.5% | 07/21/2026 |
Ann Hynes Mizuho Securities | Buy | Maintained | $493.00 | +33.3% | 07/21/2026 |
Ryan Langston TD Cowen | Hold | Maintained | $430.00 | +16.3% | 07/19/2026 |
Scott Fidel Goldman Sachs | Buy | Reiterated | $490.00 | +32.5% | 07/16/2026 |
Ben Hendrix RBC Capital | Buy | Reiterated | $478.00 | +29.2% | 07/16/2026 |
Erin Wright Morgan Stanley | Buy | Reiterated | $529.00 | +43% | 07/17/2026 |
Kevin Fischbeck Bank of America Securities | Buy | Reiterated | $512.00 | +38.4% | 07/17/2026 |
Whit Mayo Leerink Partners | Buy | Reiterated | - | - | 07/17/2026 |
David S Macdonald Truist Financial | Buy | Reiterated | $500.00 | +35.2% | 07/17/2026 |
David Toung Argus Research | Buy | Maintained | $470.00 | +27.1% | 07/17/2026 |
Michael Ha Robert W. Baird | Hold | Upgraded | $453.00 | +22.5% | 07/17/2026 |
Michael Wiederhorn Oppenheimer | Buy | Reiterated | $500.00 | +35.2% | 07/17/2026 |
Jessica Tassan Piper Sandler | Buy | Maintained | $475.00 | +28.4% | 07/15/2026 |
Matthew Gillmor CFA KeyBanc | Buy | Maintained | $475.00 | +28.4% | 07/14/2026 |
Sidharth Sahoo HSBC | Hold | Maintained | $380.00 | +2.7% | 07/06/2026 |
Michael Craig Jones Bank of America Securities | Buy | Reiterated | $475.00 | +28.4% | 06/24/2026 |
John Ransom Raymond James | Buy | Maintained | $370.00 | +0% | 04/22/2026 |
David Windley Jefferies | Buy | Maintained | $373.00 | +0.9% | 04/20/2026 |
Bram Kaplan J.P. Morgan | Buy | Maintained | $389.00 | +5.2% | 02/02/2026 |
Sarah James Cantor Fitzgerald | Buy | Maintained | $440.00 | +19% | 01/28/2026 |
Next call in 11 days
Tue, Oct 13, 2:00 PM
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $4.15
Revenue / Est. (USD)
- / 111.49B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 113.16B | 113.61B | 111.72B | 112.03B |
Cost of goods sold | 92.52B | 94.10B | 86.31B | 88.73B |
Cost of revenue | 92.52B | 94.10B | 86.31B | 88.73B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 15.22B | 15.60B | 15.39B | 14.27B |
Operating expense | 16.32B | 16.71B | 16.42B | 15.31B |
Total operating expenses | 108.85B | 110.81B | 102.73B | 104.04B |
Operating income | 4.32B | 2.80B | 8.99B | 7.99B |
Other non operating income | - | - | - | - |
EBT including unusual items | 3.23B | -720.00M | 7.96B | 6.97B |
EBT excluding unusual items | 3.31B | 1.83B | 8.04B | 7.03B |
Income tax expense | 686.00M | -938.00M | 1.48B | 1.30B |
Effective tax rate | 21.24% | 130.28% | 18.61% | 18.63% |
Other operating expenses | - | - | - | - |
Net income | 2.35B | 10.00M | 6.28B | 5.48B |
Net profit margin | 2.07% | 0.01% | 5.62% | 4.89% |
Earnings per share | 2.92 | 2.11 | 7.23 | 6.38 |
Interest and investment income | - | - | - | - |
Interest expense | -1.00B | -974.00M | -955.00M | -962.00M |
Net interest expenses | -1.00B | -974.00M | -955.00M | -962.00M |
Depreciation and amortization charges | 1.10B | 1.12B | 1.03B | 1.04B |
EBITDA | 5.41B | 3.92B | 10.02B | 9.03B |
Gain or loss from assets sale | 83.00M | -784.00M | 72.00M | 61.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1